RxDoctor Payments Data

Suzanne Richardson, PA

Medical · Puyallup, WANPI 1417068263

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.1% of the total across 405 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,059in general payments, 2019–2025

Across 405 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$1K
  • Novartis$742
  • Pfizer$518
  • E.r. Squibb & Sons, L.L.C.$467
  • Amgen$437
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$6,64094%
  • Education$4196%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,059 in reported general payments places this provider in the 95th percentile of 457 medical providers in Washington.

See all medical providers in Washington

Medicare billing

Part B allowed, 2024
$157,762
Medicare patients
806
Services billed
2,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$187,238
Cosentyx Unoready PenSecukinumab12$103,407
XolairOmalizumab26$77,904
Clobetasol Propionate145$5,679
Fluorouracil51$3,775
Calcipotriene21$2,656
Ketoconazole112$1,856
Metronidazole27$1,333
Triamcinolone Acetonide116$1,318
ValacyclovirValacyclovir Hcl29$1,080
Doxycycline Hyclate44$1,072
Fluocinolone AcetonideFluocinolone/Shower Cap15$788
Ciclopirox19$688
Minocycline Hcl12$621
Spironolactone20$619

Paid to pharmacies, not to this prescriber.

Other medical in Puyallup

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →